Comind was founded by James Dacombe in 2018.

Who are Comind's investors?

Comind's investors include Angelini Ventures, Backed, Crane Venture Partners, LocalGlobe, Octopus Ventures, Phoenix Court.

Comind

Founded 2018 · 87 employees on LinkedIn · 6 known investors

Find your way into Comind

Paths you didn't know you had: your email and LinkedIn already hold routes to the Comind team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CoMind develops neuromonitoring devices and neural interfaces aimed at measuring and treating the brain to improve patient outcomes across the care continuum. It operates in the medical device and neurotechnology space serving clinical and healthcare settings.

Deep Tech Hardware Healthtech Medical Devices

Founders & leadership

Comind was founded in 2018 by James Dacombe.

James DacombeFounder, CEOFounder at Olix

Simon MorlingChief Technology Officer

Rob CooperChief Scientific OfficerRob Cooper is a medical physicist with expertise in biomedical optics and optical imaging for the brain. He serves as Chief Scientific Officer at CoMind, leads the DOT-HUB research group at UCL, and co-directs NeoLAB at the Rosie Hospital in Cambridge.

Chema Garcia-SotoChief Commercial OfficerChema Garcia-Soto spent a decade at Medtronic in medical technology roles, where he led the acquisition of Cardiored and supported post-acquisition integrations including Covidien and Touch Surgery, building relationships across global client, distributor, and investor networks. He joined CoMind as Chief Commercial Officer to apply his medtech experience to the company's neuromonitoring and neural interface platform.

Marc BloomChief Medical OfficerHe brings expertise in neuroanaesthesiology, neurophysiology, and biological signal analysis.

Investors · 6

Angelini Ventureslisted by Angelini VenturesRome

How we know: Angelini Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Backedlisted by BackedLondon · $500K – $5M

How we know: Backed's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Crane Venture Partnerslisted by Crane Venture PartnersLondon · $750K – $3M

How we know: Crane Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us

LocalGlobelisted by LocalGlobeLondon

How we know: phoenixcourt.vc · Not right? Tell us

Octopus Ventureslisted by Octopus VenturesLondon · $130K – $1.3M

How we know: the VCSheet dataset · Not right? Tell us

Phoenix Courtlisted by Phoenix CourtLondon

How we know: Phoenix Court's portfolio page · Not right? Tell us

Founder mafia

3 people who came through Comind went on to found or lead other companies.

Krishna VisvanathanSeed Investor & Board ObserverFounded Crane Samuel JellardResearch And Development EngineerFounded Niostem James DacombeFounder and Chief Executive OfficerFounded OLIX

Frequently asked questions

What does Comind do?: CoMind develops neuromonitoring devices and neural interfaces aimed at measuring and treating the brain to improve patient outcomes across the care continuum. It operates in the medical device and neurotechnology space serving clinical and healthcare settings.
Who founded Comind?: Comind was founded by James Dacombe in 2018.
Who are Comind's investors?: Comind's investors include Angelini Ventures, Backed, Crane Venture Partners, LocalGlobe, Octopus Ventures, Phoenix Court.